On cotton, new capital and comebacks to come
By GREGORY ZELLER // Capital infusions and superstar strategic advisors couldn’t save Applied DNA Sciences from another bottom-line beating in the first quarter of Fiscal 2017 – but the biotech appears ready to punch…
